These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35239598)

  • 1. Anosognosia and Memory Encoding in Huntington Disease.
    Considine CM; Hughes S; Sellers Gibson J; Isaacs D; McDonell K; Darby RR; Claassen D
    Cogn Behav Neurol; 2022 Mar; 35(1):40-48. PubMed ID: 35239598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Awareness of deficits and anosognosia in Alzheimer's disease].
    Antoine C; Antoine P; Guermonprez P; Frigard B
    Encephale; 2004; 30(6):570-7. PubMed ID: 15738860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anosognosia Is Associated With Greater Caregiver Burden and Poorer Executive Function in Huntington Disease.
    Wibawa P; Zombor R; Dragovic M; Hayhow B; Lee J; Panegyres PK; Rock D; Starkstein SE
    J Geriatr Psychiatry Neurol; 2020 Jan; 33(1):52-58. PubMed ID: 31213121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosognosia in HD: Comparison of self-report and caregiver ratings with objective performance measures.
    Hughes SB; Churchill E; Smirnova A; Hall A; Culbert B; Snell C; Wright BA; Gilbert PE; Corey-Bloom J
    Parkinsonism Relat Disord; 2023 Feb; 107():105272. PubMed ID: 36610230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Anosognosia on Clinical and Patient-Reported Assessments of Psychiatric Symptoms in Huntington's Disease.
    Isaacs D; Gibson JS; Stovall J; Claassen DO
    J Huntingtons Dis; 2020; 9(3):291-302. PubMed ID: 32925080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a performance-rating method to assess awareness of cognitive functioning in Huntington's disease.
    Hergert DC; Haaland KY; Cimino CR
    Clin Neuropsychol; 2020 Apr; 34(3):477-497. PubMed ID: 31322031
    [No Abstract]   [Full Text] [Related]  

  • 7. Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington's disease.
    Andrews SC; Craufurd D; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Stout JC
    Neuropsychology; 2018 Nov; 32(8):958-965. PubMed ID: 30211612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural MRI Correlates of Anosognosia in Huntington's Disease.
    Hinkle JT; Wildermuth E; Tong XJ; Ross CA; Bang J
    J Huntingtons Dis; 2024; 13(3):315-320. PubMed ID: 39269851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between memory impairment and depressive symptoms can exacerbate anosognosia: a comparison of Alzheimer's disease with mild cognitive impairment.
    Oba H; Matsuoka T; Imai A; Fujimoto H; Kato Y; Shibata K; Nakamura K; Narumoto J
    Aging Ment Health; 2019 May; 23(5):595-601. PubMed ID: 29528693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anosognosia on patient-reported outcomes for psychiatric symptoms and quality of life in Huntington's disease.
    Isaacs DA; Hay KR; Hoadley J; McDonell KE; Brown AE; Wynn A; Claassen DO; Gibson J
    Parkinsonism Relat Disord; 2024 Jun; 123():106969. PubMed ID: 38614044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anosognosia in patients with Alzheimer's disease: current perspectives.
    Tagai K; Nagata T; Shinagawa S; Shigeta M
    Psychogeriatrics; 2020 May; 20(3):345-352. PubMed ID: 31930617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease.
    Senturk G; Bilgic B; Arslan AB; Bayram A; Hanagasi H; Gurvit H; Emre M
    Int Psychogeriatr; 2017 Feb; 29(2):293-302. PubMed ID: 27780496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.
    Orfei MD; Assogna F; Pellicano C; Pontieri FE; Caltagirone C; Pierantozzi M; Stefani A; Spalletta G
    Parkinsonism Relat Disord; 2018 Sep; 54():62-67. PubMed ID: 29709507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of Chorea in Huntington's Disease.
    Hergert DC; Sanchez-Ramos J; Cimino CR
    J Huntingtons Dis; 2020; 9(1):99-103. PubMed ID: 31707371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroanatomical and cognitive correlates of domain-specific anosognosia in early Alzheimer's disease.
    Valera-Bermejo JM; De Marco M; Mitolo M; McGeown WJ; Venneri A
    Cortex; 2020 Aug; 129():236-246. PubMed ID: 32534349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.
    Smith MM; Mills JA; Epping EA; Westervelt HJ; Paulsen JS;
    Neuropsychology; 2012 Sep; 26(5):664-9. PubMed ID: 22846033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological Correlates of Anosognosia for Objective Functional Difficulties in Older Adults on the Mild Cognitive Impairment Spectrum.
    Steward KA; Bull TP; Kennedy R; Crowe M; Wadley VG
    Arch Clin Neuropsychol; 2020 May; 35(4):365-376. PubMed ID: 31875876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington study group's neuropsychology working group position on best practice recommendations for the clinical neuropsychological evaluation of patients with Huntington disease.
    Considine CM; Rossetti MA; Anderson K; Del Bene VA; Anderson SA; Celka AS; Edmondson MC; Sheese ALN; Piccolino A; Teixeira AL; Stout JC
    Clin Neuropsychol; 2024 May; 38(4):984-1006. PubMed ID: 37849335
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence.
    Julayanont P; McFarland NR; Heilman KM
    J Neurol Sci; 2020 Jan; 408():116523. PubMed ID: 31678902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.